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Conclusion:
In conlusion we note that in women, who present with bilateral breast lumps, synchronous tumours should be considered as a possibility of malignancy and investigate for distant metastasis at presentation should be routine even in those who are asymptomatic. It is relatively a rare neoplasm. Only few cases have been reported in the literature. Further study is recommended. A whole body bone scan confirmed on 5 th January 2009 revealed: normal whole body bone scan.
Discussion
Synchronous tumours are defined as two or more tumours where each are malignant, occurring simultaneously and where neither can originate with metastasis from another tumour 2 . Our patients bilateral multiple tumours were consistent with this definition of being synchronous. Bilateral synchronous breast cancer is an uncommon finding in women presenting with multiple breast lumps. It is reported to account for only 2% of women with breast cancer whereas metachronous breast tumours account for 5% of cancer cases 3 . The overall incidence of multiple primary cancers among cancer patients is 0.83%. The interval between the onsets of two cancers varies from 1 month to 30 years. The majority of the patients are male. The most commonly diagnosed multiple primary cancers are larynx and lung cancers, followed by lip and larynx cancers. Such malignancies, which occur together, probably have similar etiopathogenetic mechanisms 6 . The incidence of synchronous or metachronous contralateral breast cancer was reported as 2.7% in male breast cancer patients, similar to that of women 4 . However, the incidence of synchronous or metachronous cancer was reported as 10.6% for male breast cancer patients, higher than that of women 4 . However it appears that this familial link is more likely with metachronous bilateral breast cancer than either unilateral or synchronous bilateral cases. Furthermore the risk of having breast cancer is substantially increased with a first degree relative with bilateral breast cancer 1 .
Such type of patients are lower disease free survival and high rates of distant metastasis is a recognised feature of bilateral synchronous tumours which therefore has a worse overall survival compared to unilateral tumours 3 . There does not however appear to be any difference in survival if synchronous tumours are compared to the metachronous
